Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.
iwAL 2018 day 2 discussion: novel approaches and targeted therapies in AML
Andrew Wei et al.
Understanding the genetic risks of CLL
Doublet vs triplet combination therapy for multiple myeloma
Treatment for older AML patients - when is an allogeneic transplant suitable?